Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride
Status:
Terminated
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Magnesium iron hydroxycarbonate is a phosphate binder that absorbs phosphate from food,
reducing the amount that the body can absorb.
The purpose of this study is to assess the efficacy of magnesium iron hydroxycarbonate in
subjects requiring haemodialysis, compared with a marketed phosphate binder, sevelamer
hydrochloride.